Mode
Text Size
Log in / Sign up
Phase 4 Completed N=109 Randomized Triple-blind Treatment

Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese Patients

Surgical Conditions
Source: ClinicalTrials.gov NCT02553629 ↗
Enrolled (actual)
109
Serious AEs
0.0%
Results posted
Feb 2017
Primary outcomePrimary: Surgical Rating — 4.2; 4.8 units on a scale — p=0.001
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

This is a randomized control trial (RCT) that studies the surgical conditions during moderate and deep neuromuscular blockade in 100 morbidly obese patients receiving elective laparoscopic surgery for bariatric surgery.

Outcome Measures

OutcomeResultp-value
PRIMARY
Surgical Rating
4.2; 4.8 0.001 sig
SECONDARY
Extubation
3; 3 >0.05
SECONDARY
Pain
4.4; 3.9 0.04 sig
SECONDARY
Respiration
12.7; 12.6 >0.05
SECONDARY
Mean Arterial Blood Pressure
98; 101 >0.05

Eligibility Criteria

Inclusion Criteria

  • ASA I-III
  • BMI > 34 kg/m2
  • Elective bariatric surgery.

Exclusion Criteria

  • Known or suspected neuromuscular disorders impairing neuromuscular function
  • Allergies to muscle relaxants, anesthetics or narcotics
  • A(family) history of malignant hyperthermia
  • Women who are or may be pregnant or are currently breast feeding
  • Renal insufficiency, as defined by serum creatinine x 2 of normal, or urine output < 0.5 ml/kg/h for at least 6 h.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02553629). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search